The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated

被引:65
|
作者
Gómez-Lozano, N
Estefanía, E
Williams, F
Halfpenny, I
Middleton, D
Solís, R
Vilches, C
机构
[1] Hosp Univ Puerta Hierro, Serv Inmunol, Madrid 28035, Spain
[2] Belfast City Hosp, No Ireland Reg Histocompatibil & Immnuogenet Lab, Belfast BT9 7AD, Antrim, North Ireland
关键词
KIR; evolution; gene regulation; human; NK cell;
D O I
10.1002/eji.200425493
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Killer-cell Ig-like receptors (KIR) are structurally and functionally diverse, and enable human NK cells to survey the expression of individual HLA class I molecules, often altered in infections and tumors. Multiple events of non-reciprocal recombination have contributed to the rapid diversification of KIR. We show that similar to4.5% of the individuals of a Caucasoid population bear a recombinant allele of KIR3DP1, officially designed KIR3DP1*004, that associates tightly with gene duplications of KIR3DP1, KIR2DL4 and KIR3DL1/K1R3DS1. The KIR3DP1 gene is normally silent, but the recombinant allele carries a novel promoter sequence and, as a consequence, is transcribed in all tested individuals. Messenger RNA of KIR3DP1*004 is made up of six exons; of these, exons 1-5 are similar to, and spliced like, those encoding the leader peptide and Ig-domains of KIR3D. By contrast, exon 6 is homologous to no other human KIR sequence, but only to possible homologs in chimpanzees and rhesus macaques, and encodes a short hydrophilic tail. The putative KIR3DP1*004 product, like those of the related genes LAIR-2 and LILRA3/ILT6/LIR4, is predicted to be secreted to the extracellular medium rather than anchored to the cell membrane.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 50 条
  • [21] Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population
    Gagne, Katia
    Willem, Catherine
    Legrand, Nolwenn
    Djaoud, Zakia
    David, Gaelle
    Rettman, Pauline
    Bressollette-Bodin, Celine
    Senitzer, David
    Esbelin, Julie
    Cesbron-Gautier, Anne
    Schneider, Thierry
    Retiere, Christelle
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (04) : 1085 - 1098
  • [22] The combination of a low expressing KIR3DL1 allotype and KIR3DS1 contributes toward the risk of developing Behcet's disease
    Petrushkin, H.
    Norman, P.
    Wallace, G.
    Stanford, M.
    Parham, P.
    Fortune, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S154 - S154
  • [23] Characterization of the novel KIR3DL1*0150213 and KIR3DL1*112 alleles using sequence-based typing
    Jia, Jie
    Lin, Ke-Qin
    Huang, Kai
    Dai, Jie-Jie
    Yang, Zhao-Qing
    HLA, 2019, 94 (01) : 90 - 91
  • [24] Novel KIR3DL1 alleles and their expression levels on NK cells:: Convergent evolution of KIR3DL1 phenotype variation?
    Thomas, Rasmi
    Yamada, Eriko
    Alter, Galit
    Martin, Maureen P.
    Bashirova, Arman A.
    Norman, Paul J.
    Altfeld, Marcus
    Parham, Peter
    Anderson, Stephen K.
    McVicar, Daniel W.
    Carrington, Mary
    JOURNAL OF IMMUNOLOGY, 2008, 180 (10): : 6743 - 6750
  • [25] PHASED WHOLE-GENE CHARACTERIZATION OF NOVEL KIR3DL1, KIR3DL2, AND KIR3DL3 ALLELES USING A DUAL REDUNDANT SEQUENCING STRATEGY
    Lang, Kathrin
    Guenther, Marie
    Bentink, Stefan
    Schmidt, Alexander H.
    Schoefl, Gerhard
    Lange, Vinzenz
    HUMAN IMMUNOLOGY, 2017, 78 : 133 - 133
  • [26] Expression profile of KIR3DS1/KIR3DL1 receptors in association with immunological responses in TB, HIV and HIV/TB infected patients
    Shaukat, Sobia Naz
    Nasir, Faizan
    Raza, Afsheen
    Khanani, Rafiq
    Uddin, Shahab
    Kazmi, Shahana Urooj
    MICROBIAL PATHOGENESIS, 2023, 180
  • [27] ALLELIC TYPING OF KIR2DL1 AND KIR3DL1 GENES TO IMPROVE DONOR SELECTION IN STEM CELL TRANSPLANTATION
    Becker, Petra S. A.
    Klemm, Dido A.
    Hennecke, Johannes F.
    Richter, Rudolf
    Seifried, Erhard
    Seidl, Christian
    TISSUE ANTIGENS, 2015, 85 (05): : 392 - 393
  • [28] DIFFERENTIAL REGULATION OF THE KIR2DL1+, KIR2DL2/3+, AND KIR3DL1+NK CELL ACTIVITY ACCORDING TO THE KIR HLA LIGAND MECHANISM
    Richter, Rudolf
    Becker, Petra S. A.
    Dombos, Sara
    Hennecke, Johannes F.
    Seifried, Erhard
    Seidl, Christian
    TISSUE ANTIGENS, 2013, 81 (05): : 293 - 294
  • [29] Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC
    Lisovsky, Irene
    Kant, Sanket
    Tremblay-McLean, Alexandra
    Isitman, Gamze
    Kiani, Zahra
    Dupuy, Franck P.
    Gilbert, Louise
    Bruneau, Julie
    Shoukry, Naglaa H.
    Lebouche, Bertrand
    Bernard, Nicole F.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (03) : 551 - 563
  • [30] KIR2DL2 AND KIR3DS1 AND IL28B ASSOCIATION WITH HCV RESOLUTION
    Fabricio-Silva, Gustavo
    Castilho, Magda
    Cardoso-Oliveira, Juliana
    Almeida, Bruno
    Perez, Renata
    Figueiredo, Fatima
    Al-Cici, Raquel
    Porto, Luis Cristovao
    HUMAN IMMUNOLOGY, 2013, 74 (05) : 496 - 496